InsidersTradesSigma
Total declarations
Company
▲ Purchases (63 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
63
Disclosed sells
0
T+90 hit rate
30%
T+90 mean return
-15.5%
Across 46 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Niihara Yutaka, Chairman and Chief Executive Officer. Insider active across 1 company, notably Emmaus Life Sciences, Inc.. Cumulatively, 63 filings have been published. Breakdown: 63 buys · 0 sell. Total volume traded: €427k. Activity tracked since 6 May 2021. The latest transaction was filed on 3 November 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Niihara Yutaka
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations63 total
2,500 shares@ US$0.450.2% of flowCommon stock, $0.001 par valueSEC:0001209191-22-059154:0
Canonical exit: 1 Feb 2023 (T+90)
7,500 shares@ US$0.450.5% of flowCommon stock, $0.001 par valueSEC:0001209191-22-055471:0
Canonical exit: 29 Jan 2023 (T+90)
7,500 shares@ US$0.220.2% of flowCommon stock, $0.001 par valueSEC:0001209191-22-054902:0
Canonical exit: 22 Jan 2023 (T+90)
25,000 shares@ US$0.160.6% of flowCommon stock, $0.001 par valueSEC:0001209191-22-054449:0
Canonical exit: 17 Jan 2023 (T+90)
15,000 shares@ US$0.200.4% of flowCommon stock, $0.001 par valueSEC:0001209191-22-054051:0
Canonical exit: 15 Jan 2023 (T+90)
62,500 shares@ US$0.181.6% of flowCommon stock, $0.001 par valueSEC:0001209191-22-053757:0
Canonical exit: 11 Jan 2023 (T+90)
5,000 shares@ US$0.090.1% of flowCommon stock, $0.001 par valueSEC:0001209191-22-053559:0
Canonical exit: 9 Jan 2023 (T+90)
6,000 shares@ US$0.200.2% of flowCommon stock, $0.001 par valueSEC:0001209191-22-053433:0
Canonical exit: 25 Dec 2022 (T+90)
5,000 shares@ US$0.490.29% mcap0.3% of flowCommon stock, $0.001 par valueSEC:0001209191-22-033730:0
Canonical exit: 18 Aug 2022 (T+90)
6,000 shares@ US$0.600.42% mcap0.5% of flowCommon stock, $0.001 par valueSEC:0001209191-22-030451:0
Canonical exit: 7 Aug 2022 (T+90)
53,800 shares@ US$1.498.87% mcap10.2% of flowCommon stock, $0.001 par valueSEC:0001209191-22-014998:0
Canonical exit: 29 May 2022 (T+90)
11,000 shares@ US$1.431.72% mcap2.0% of flowCommon stock, $0.001 par valueSEC:0001209191-22-013475:0
Canonical exit: 25 May 2022 (T+90)
1,500 shares@ US$1.430.23% mcap0.3% of flowCommon stock, $0.001 par valueSEC:0001209191-22-012064:0
Canonical exit: 19 May 2022 (T+90)
1,000 shares@ US$1.470.16% mcap0.2% of flowCommon stock, $0.001 par valueSEC:0001209191-22-011119:0
Canonical exit: 17 May 2022 (T+90)
6,000 shares@ US$1.450.95% mcap1.1% of flowCommon stock, $0.001 par valueSEC:0001209191-22-010142:0
Canonical exit: 15 May 2022 (T+90)
23,500 shares@ US$1.453.69% mcap4.3% of flowCommon stock, $0.001 par valueSEC:0001209191-22-008917:0
Canonical exit: 10 May 2022 (T+90)
5,250 shares@ US$1.470.83% mcap1.0% of flowCommon stock, $0.001 par valueSEC:0001209191-22-007990:0
Canonical exit: 8 May 2022 (T+90)
6,250 shares@ US$1.400.96% mcap1.1% of flowCommon stock, $0.001 par valueSEC:0001209191-22-007395:0
Canonical exit: 4 May 2022 (T+90)
1,000 shares@ US$1.600.3% of flowCommon stock, $0.001 par valueSEC:0001209191-22-000164:0
Canonical exit: 28 Mar 2022 (T+90)
5,000 shares@ US$1.481.5% of flowCommon stock, $0.001 par valueSEC:0001209191-21-071358:0
Canonical exit: 22 Mar 2022 (T+90)
2,750 shares@ US$1.490.8% of flowCommon stock, $0.001 par valueSEC:0001209191-21-070895:0
Canonical exit: 17 Mar 2022 (T+90)
1,000 shares@ US$1.570.3% of flowCommon stock, $0.001 par valueSEC:0001209191-21-070255:0
Canonical exit: 10 Mar 2022 (T+90)
1,500 shares@ US$1.490.5% of flowCommon stock, $0.001 par valueSEC:0001209191-21-068959:0
Canonical exit: 6 Mar 2022 (T+90)
3,400 shares@ US$1.531.1% of flowCommon stock, $0.001 par valueSEC:0001209191-21-068106:0
Canonical exit: 2 Mar 2022 (T+90)
35,600 shares@ US$1.5111.1% of flowCommon stock, $0.001 par valueSEC:0001209191-21-067479:0
Canonical exit: 28 Feb 2022 (T+90)
25 of 63 declarations
About Niihara Yutaka
Niihara Yutaka is Chairman and Chief Executive Officer at Emmaus Life Sciences, Inc. (XNAS). He has 63 filings in total, and across the sampled recent filings from 2021-05-10 to 2022-12-01, the reported activity is purchases only, with EUR 427050 of buys and EUR 0 of sells.
